Benign Prostatic Hyperplasia (BPH)
π΄π½ Benign Prostatic Hyperplasia (BPH)
NP Student Educational Guide
β Definition
Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate gland, commonly seen in aging men. It leads to lower urinary tract symptoms (LUTS) due to urethral compression and bladder outlet obstruction.
π Epidemiology
Very common in men >50 years old
~50% of men by age 60
~90% by age 85
Not all men with BPH develop symptoms
𧬠Pathophysiology
BPH involves hyperplasia of prostatic stromal and epithelial cells, mostly in the transition zone.
Androgens (especially dihydrotestosterone, DHT) drive prostate growth.
As the prostate enlarges, it compresses the urethra, leading to bladder outflow obstruction and urinary symptoms.
π½ Clinical Presentation
LUTS = Lower Urinary Tract Symptoms
πΉ Voiding (Obstructive) Symptoms:
Weak urinary stream
Hesitancy
Straining
Incomplete emptying
Intermittency
Dribbling
πΉ Storage (Irritative) Symptoms:
Urgency
Frequency
Nocturia
Urge incontinence (less common)
π Hematuria or UTIs may occur with chronic retention.
π History & Physical Exam
π History:
Symptom onset and severity
Impact on quality of life
Medication use (anticholinergics, decongestants)
Voiding pattern, nocturia, incontinence
π¨π½ββοΈ Physical Exam:
Digital Rectal Exam (DRE):
Enlarged, smooth, firm, nontender prostate
Nodules β rule out prostate cancer
Abdominal exam for bladder distension
π§ͺ Diagnostic Workup
Test | Purpose |
|---|---|
UA (Urinalysis) | Rule out UTI or hematuria |
PSA (optional) | Screen for prostate cancer (controversial in BPH) |
Serum creatinine | Check renal function if retention is suspected |
Post-void residual (PVR) | Bladder scan or cath after voiding |
IPSS (International Prostate Symptom Score) | Symptom assessment (mild, moderate, severe) |
π Management
πΉ 1. Watchful Waiting
For mild symptoms (IPSS 0β7)
Lifestyle changes:
Limit fluids before bed
Avoid caffeine/alcohol
Timed voiding
Avoid decongestants and anticholinergics
πΉ 2. Pharmacologic Therapy
Class | Example | Mechanism | Notes |
|---|---|---|---|
Alpha-1 blockers | Tamsulosin, Terazosin | Relax prostate/bladder neck smooth muscle | Fast symptom relief in days |
5-alpha reductase inhibitors | Finasteride, Dutasteride | Shrink prostate by blocking DHT | Takes months; β PSA by 50% |
Combination therapy | Tamsulosin + Finasteride | Dual benefit for larger prostates | Better long-term outcomes |
Anticholinergics | Oxybutynin | Reduce bladder irritability | Use if irritative symptoms dominate |
Beta-3 agonists | Mirabegron | Improve bladder capacity | Alternative to anticholinergics |
β Always assess post-void residual before starting anticholinergics β risk of retention.
πΉ 3. Surgical Options
Consider if:
Failed medical therapy
Recurrent urinary retention
Recurrent UTIs or bladder stones
Hematuria or hydronephrosis from BPH
Procedures include:
TURP (transurethral resection of prostate) β gold standard
Laser therapy
UroLift or Rezum β newer, minimally invasive options
π© When to Refer to Urology
Gross hematuria
Elevated PSA
Abnormal DRE (nodules)
Recurrent urinary retention or UTIs
Renal impairment due to obstruction
Failure of medical management
π©ββ NPβs Role
Identify symptoms early
Educate patients on lifestyle modifications
Initiate and monitor medication therapy
Monitor for complications (retention, hematuria)
Collaborate with urology when needed
π§ Clinical Pearl
A sudden worsening of urinary symptoms in a man with BPH may be due to:
UTI
Medication side effects (antihistamines, anticholinergics)
Bladder stones
Prostate cancer